New Diabetes Drug News Articles

New Diabetes Drug Canagliflozin By J&J To Enter Market

A new type 2 diabetes drug by Johnson & Johnson, called Canagliflozin, has been approved by the U.S. Food and Drug Administration (FDA) committee with a vote of 10 to 5. The Endocrinologic and Metabolic Drug Advisory Committee by a […]